Literature DB >> 4133192

Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. II. Bleomycin and hydroxyurea.

F Mauro, B Falpo, G Briganti, R Elli, G Zupi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4133192     DOI: 10.1093/jnci/52.3.715

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Growth phase dependency of chromatin cleavage and degradation by bleomycin.

Authors:  C W Moore; C S Jones; L A Wall
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development.

Authors:  Leandro Honorato; Jhon Jhamilton Artunduaga Bonilla; Alicia C Piffer; Leonardo Nimrichter
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

Review 3.  [On the problem of praetherapeutic sensitivity testing of human tumours based on incorporation studies of nucleic acid precursors in vitro (author's transl)].

Authors:  S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1977-12-01

4.  New type of recovery in HeLa cells exposed to bleomycin.

Authors:  T Miyamoto; M Wakabayashi; T Terasima
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

5.  Changes in sensitivity to radiation and to blemycin occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

6.  The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

7.  Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents.

Authors:  O I Epifanova; I N Smolenskaya; V A Polunovsky
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.